Зміст
Добірка наукової літератури з теми "Évènements cardiovasculaires majeurs"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Évènements cardiovasculaires majeurs".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Évènements cardiovasculaires majeurs"
Marre, M., N. Poulter, J. Mann, V. Fonseca, O. Mosenzon, I. Raz, H. Frimer-Larsen, B. J. Von Scholten, and T. Idorn. "Le liraglutide diminue les évènements cardiovasculaires majeurs chez les diabétiques de type 2 avec maladie rénale chronique : une analyse de l’étude LEADER." Annales d'Endocrinologie 79, no. 4 (September 2018): 265. http://dx.doi.org/10.1016/j.ando.2018.06.201.
Повний текст джерелаFakih, O., M. Desmarets, B. Martin, C. Prati, D. Wendling, E. Monnet, and F. Verhoeven. "Incidence des évènements cardiovasculaires majeurs chez les patients français atteints de spondyloarthrite nouvellement bénéficiaires de l’affection longue durée : étude sur le Système national des données de santé." Revue du Rhumatisme 89 (December 2022): A119—A120. http://dx.doi.org/10.1016/j.rhum.2022.10.172.
Повний текст джерелаRossignol, P., J. Cridlig, P. Lehert, F. Zannad, and M. Kessler. "La variabilité inter-visite de la pression artérielle est un prédicteur majeur des évènements cardiovasculaires en insuffisance rénale terminale. Données de l’étude FOSIDIAL (Fosinopril in dialysis)." Néphrologie & Thérapeutique 7, no. 5 (September 2011): 277. http://dx.doi.org/10.1016/j.nephro.2011.07.043.
Повний текст джерелаLensel, A. S., P. Lermusiaux, C. Boileau, P. Feugier, A. Sérusclat, Y. Zerbib, and J. Ninet. "La connaissance des facteurs de risque cardiovasculaire est-elle meilleure après la survenue d’un évènement ischémique majeur ? Enquête auprès de 135 cas et 260 témoins." Journal des Maladies Vasculaires 38, no. 6 (December 2013): 360–66. http://dx.doi.org/10.1016/j.jmv.2013.10.001.
Повний текст джерелаFarouk Boukerche and Leila Hammou. "Stratification du risque dans le SCA sans sus décalage du segment ST dans une population Oranaise : « Etude ORAN »." Journal de la faculté de médecine d'Oran 2, no. 2 (December 31, 2018). http://dx.doi.org/10.51782/jfmo.v2i2.71.
Повний текст джерелаДисертації з теми "Évènements cardiovasculaires majeurs"
Jacquin, Laurent. "Déséquilibre d’oxygénation et lésions myocardiques aiguës : approche clinique en service d’accueil des urgences." Thesis, Lyon, 2021. https://n2t.net/ark:/47881/m6736qrr.
Повний текст джерелаIn the first part, we were interested in the criteria of oxygen supply/demand imbalance involved in the occurrence of a type 2 infarction. We explored in 610 patients the association between the parameters of these criteria and the occurrence of acute myocardial injury and type 2 infarction, as well as the correlation between these parameters and the extent of myocardial injury. Our results did not show any association between the importance of oxygen mismatch and the occurrence of acute myocardial injury. There was also no correlation with the magnitude of such injury. Therefore, we could not define strict restrictive thresholds that could be considered a significant myocardial stressor. In the second part, we compared the short-term and the long-term outcomes of patients admitted with an oxygen supply/demand imbalance condition according to the presence of myocardial injury or type 2 infarction and assessed the association of these pathological entities with mortality and major cardiovascular events. In this population of 824 patients, the occurrence of myocardial injury or type 2 infarction led to high in-hospital mortality of more than 20% and was significantly associated with it after adjustment for patient characteristics. In the follow-up of survivors, the outcome was dependent on comorbidities without the involvement of the occurrence of these initial myocardial injuries, with mortality rates of 27 to 35% and major cardiovascular events of 23 to 40%. We proposed to compare these results in another study, conducted prospectively, with a standardized 6-month follow-up of patients admitted for oxygenation failure, the methods of which are detailed here. This cohort consists of 670 patients whose data are currently being analyzed. Finally, in the third part, we focused on the 675 elderly patients, who represent more than 80% of our cohort, to determine the factors associated with the occurrence of these myocardial injuries and type 2 infarction according to age classes. We found very dependent patient profiles in these classes, linked to the epidemiological changes of aging. However, the individualization of type 2 myocardial infarction within acute myocardial lesions was not obvious, nor was the impact on mortality, which was essentially based on the burden of comorbidities